Gail Levine is a partner in Mayer Brown's Washington DC office, where she co-leads the firm’s global Antitrust & Competition practice. She joined Mayer Brown from the US Federal Trade Commission’s (FTC) Bureau of Competition, where she served as a deputy director under Chairman Joseph Simons and Acting Chairwoman Rebecca Slaughter.
Gail joined the FTC as a deputy director of the Bureau of Competition in 2018. In this role, she supervised over 100 lawyers in five divisions, handling all aspects of antitrust review. She oversaw a wide variety of merger reviews, anticompetitive conduct investigations and antitrust litigation, particularly in areas such as high-tech, pharmaceuticals, biotech and health care. She helped establish the new Technology Enforcement Division, which investigates anticompetitive conduct in digital markets.
Previously, she spent more than a decade in-house. She was one of Uber’s top lawyers, working as head of US regulatory affairs and as director for competition, where she counseled senior business and legal executives on emerging competition and regulatory issues. She also served as vice president and associate general counsel at Verizon Communications, where she handled antitrust and IP issues.
Prior to her tenure in-house, Gail was an attorney advisor to former FTC Chair Deborah Platt Majoras, advising on antitrust and IP matters. She was a significant contributor to the FTC’s first major report on IP and innovation and co-authored many other FTC reports. Earlier in her career, Ms. Levine was a trial attorney with the Civil Division of DOJ.
An active community member, Gail has held several leadership roles in the American Bar Association’s Section of Antitrust Law, and today she serves as a vice chair of its committee dedicated to promoting women in antitrust. She has previously served on the ABA Antitrust Section’s Council, its governing board; the ABA Presidential Transition Task Force; and the ABA Presidential Task Force on Pleading Standards. Additionally, she is a sought-after speaker and writer on antitrust and IP issues.
Areas of Focus
While at the FTC:
- Supervised FTC challenge to a next-generation gene-sequencing firm’s plan to acquire an alleged nascent competitor (Illumina/PacBio).
- Oversaw FTC’s action against a pharmaceutical firm and its corporate leadership for allegedly using anticompetitive tactics to shield its drug from price competition (FTC v. Vyera).
- Supervised the FTC’s actions against drug companies that allegedly used an anticompetitive product-hopping scheme to thwart competition with their lucrative opioid replacement therapy drug. The companies paid $60 million to settle the charges, which has been refunded to consumers.
- Helped establish, and supervised, the FTC’s Technology Enforcement Division, which investigates anticompetitive conduct in digital technology markets.
- Oversaw the FTC’s successful challenge to Peabody/Arch Coal, a proposed joint venture in the coal industry.
Harvard Law School, JD, magna cum laude
Harvard Law Review
University of Texas, BA, summa cum laude
Phi Beta Kappa; Plan II Honors Program; Outstanding Student Finalist; Dean’s Distinguished Graduate
- District of Columbia
- American Bar Association, Section of Antitrust Law: Vice Chair, Women.Connected (2020-present); Member, Council (2013-2016); Member, Long Range Planning Committee (2020-present; 2013-2014); Member, Nominating Committee (2011); Co-Chair, Communications & Digital Technologies Industry Committee (2009-2011); Vice Chair, Computer & Internet Committee (2001-2009)
- ABA Presidential Transition Task Force: Advisor on competition, innovation, and consumer protection policy (2012-2013)
- ABA Presidential Task Force on Pleading Standards (2010-2011)
- FTC's Janet Steiger Award (2019) for outstanding contributions to Chairman's 21st Century Hearings Team
- FTC's Janet Steiger Award (2004) for exceptional effort on FTC health care hearings and report
- FTC's Outstanding Team Effort Award (2003) for outstanding work on FTC's IP hearings and report